Can paxlovid beat long COVID? major trial tests antiviral for lingering symptoms
NCT ID NCT05965726
First seen Jan 23, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study tested the antiviral drug Paxlovid in 964 adults with Long COVID to see if it could improve symptoms like brain fog, dizziness, and fatigue. Participants received either a short or longer course of Paxlovid or a placebo. The goal was to find out if clearing leftover virus or calming the immune system can help people feel better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All sites listed under NCT05595369
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.